Genitourinary Radiology: Page 11

Prediction model with contrast US can gauge prostate cancer risk

By Amerigo Allegretto

A nomogram prediction model that uses contrast-enhanced ultrasound (CEUS) can help predict prostate cancer risk in men, a Chinese study published July 25 in the British Journal of Radiology found.

August 1, 2022

QT Imaging touts prostate cancer screening study

By AuntMinnie.com staff writers

QT Imaging is highlighting the results of a study conducted by researchers from the U.S. National Cancer Institute that compared its QTscan technology to 7-tesla MRI for prostate cancer screening.

July 27, 2022

Telix and BAMF use Illuccix for total-body prostate PET

By AuntMinnie.com staff writers

Telix and BAMF Health are reporting the first use for prostate cancer imaging of the Illuccix radiopharmaceutical with the uExplorer total-body PET scanner from United Imaging.

July 26, 2022

Microultrasound on par with MRI in prostate cancer detection

By Amerigo Allegretto

Microultrasound has detection rates for prostate cancer that are comparable to multiparametric MRI in men who have not yet been biopsied, a Canadian study published July 19 in Radiology found.

July 19, 2022

ECR: CT radiomics can aid in characterizing renal cysts

By Erik L. Ridley

The combination of CT radiomics and a machine-learning algorithm can help predict if a renal cyst is benign or malignant, potentially helping to avoid unnecessary surgeries, research presented at ECR 2022 indicates.

July 17, 2022

ECR: How has COVID affected cancer screening in Europe?

By Kate Madden Yee

VIENNA - The COVID-19 pandemic dramatically affected how healthcare was delivered in Europe, and oncology screening programs were not immune from its impact, according to a panel of experts that convened on July 13 at ECR 2022 in Vienna.

July 12, 2022

PSMA-PET/CT comparable to MRI for detecting prostate cancer

By Kate Madden Yee

Prostate-specific membrane antigen (PSMA)-PET/CT imaging is comparable to MRI for detecting clinically significant prostate cancer. But MRI is still the more accurate modality for detecting the grade of disease, according to research presented on July 3 at the European Association of Urology in Amsterdam, the Netherlands.

July 5, 2022

SPECT/CT proves value over CT diagnosing renal cancer

By Will Morton

SPECT/CT imaging appears more accurate than standard contrast-enhanced CT exams for diagnosing benign versus malignant kidney tumors, according to a study published June 30 in the Journal of Nuclear Medicine.

July 5, 2022

Insightec nabs IDE for HIFU technology

By AuntMinnie.com staff writers

Insightec has received an investigational device exemption (IDE) from the U.S Food and Drug Administration (FDA) for a clinical study of its Exablate Prostate system to treat diseased prostate tissue.

June 30, 2022

Insightec highlights Exablate Prostate system study results

By AuntMinnie.com staff writers

Insightec is highlighting a study that shows the company's Exablate Prostate system is a safe and effective alternative treatment option for patients with intermediate-risk prostate cancer, according to results published June 14 in the Lancet Oncology.

June 23, 2022

Echosens, Novo Nordisk partner on liver disease campaign

By AuntMinnie.com staff writers

Echosens and Novo Nordisk are partnering on research support for early diagnosis of nonalcoholic steatohepatitis, as well as increased awareness of the disease.

June 23, 2022

Blue Earth touts positive prostate cancer trial results

By AuntMinnie.com staff writers

Blue Earth Therapeutics is highlighting clinical study results that suggest that its radiopharmaceutical labeled with lutetium-177 is effective for treating metastatic, castrate-resistant prostate cancer.

June 15, 2022

Previous Page

Page 11 of 93

Next Page